Author

A. Boureille 1

1 CHU Nantes,Nantes,France

Comparison of vedolizumab and infliximab efficacy in ulcerative colitis after failure of a first subcutaneous anti-TNF agent: a multicentre cohort study

Marianne Hupé, Pauline Riviere, Stéphane Nancey, Xavier Roblin, Romain Altwegg, Jerome Filippi, Mathurin Fumery, Guillaume Bouguen, Laurent Peyrin-Biroulet, A. Boureille, Ludovic Caillo, Félix Goutorbe, Mireille Simon, David Laharie

CT-Scout<sup>TM</sup> platform, the digital solution to boost patient recruitment in inflammatory bowel disease clinical trials: a multicenter prospective observational comparative study involving 134 sites and 644 patients in 6 countries

Yoram Bouhnik, Xavier Hebuterne, Raith Mrad, Aurelien Amiot, Carmen Stefanescu, David Laharie, Xavier Roblin, A. Boureille, Norman Sabbah, Laurent Peyrin-Biroulet

EFFICACY AND SAFETY OF TNF ANTAGONIST FOR THE TREATMENT OF INTERNAL FISTULIZING CROHN'S DISEASE

Audrey Huguet, Laurent Siproudhis, V. Desfourneaux, Jean-François Bretagne, Franck Cholet, A. Boureille, Guillaume Bouguen

Nomenclature and Semantic Description of Ulcerative and Inflammatory Lesions seen in Crohn's Disease in Small Bowel Capsule Endoscopy: an International Delphi Consensus Statement

Romain Leenhardt, Anthony Buisson, A. Boureille, Philippe Marteau, Anastasios Koulaouzidis, Cynthia Li, Martin Keuchel, Emanuele Rondonotti, Ervin Toth, John Nicholas Plevris, Abraham (Rami) Eliakim, Bruno Rosa, Konstantinos Triantafyllou, Luca Elli, G. Wurm-Johansson, Pierre Ellul, Enrique Perez-Cuadrado-Robles, Deirdre M

Item 1 - 4 / 5
1